Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy - Investor's Business Daily

Novo Nordisk (NVO) stock slumped Wednesday after the drugmaker said it expects continued competition this year from "unsafe and unlawful" copycat versions of its blockbuster obesity drug, Wegovy. Th…